AMPLIFY: A second-generation BTK inhibitor for fixed-duration therapy in chronic lymphocytic leukemia

Stefano Molica1

  • 1Department of Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK.

Med (New York, N.Y.)
|April 12, 2025
PubMed
Abstract